Vaxcyte Inc expected to post a loss of 74 cents a share - Earnings Preview

Vaxcyte

04/08/2023 15:33

* Vaxcyte Inc  PCVX.OQ   PCVX.O  is expected to show no
change in
quarterly revenue when it reports  results on August 7
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Vaxcyte Inc is for
a loss
of 74 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 9 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Vaxcyte Inc
is
$69​, above​ its last closing price of $48.82. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.84       -0.83      -0.70     Beat    15.2
 Dec. 31 2023  -0.98       -0.93      -1.02     Missed  -9.7
 Sep. 30 2022  -0.84       -0.84      -0.93     Missed  -11.2​
 Jun. 30 2022  -0.69       -0.69      -0.80     Missed  -15.9
 ​​Mar.        -0.64       -0.63      -0.68     Missed  -8.5
 31 2022                                                
 Dec. 31 2021  -0.52       -0.56      -0.55     Beat    1.8​
 Sep. 30 2021  -0.53       -0.55      -0.51     Beat    6.7
 Jun. 30 2021  -0.53       -0.52      -0.46     Beat    12.1
 This summary was machine generated August 4 at 14:32 GMT.  All
figures in US dollars  unless otherwise stated